eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | c syndrome |
| Comorbidity | C0036341|schizophrenia |
| Sentences | 54 |
| PubMedID- 22754543 | Finally, preliminary evidence suggests that folate supplementation, which may restore balance of the aldo met cycle, improves endothelial function in schizophrenia patients with metabolic syndrome (ellingrod et al., 2012). |
| PubMedID- 23960421 | Despite expected controversies, some patient-related risk factors for the development of metabolic syndrome in patients with schizophrenia receiving atypical antipsychotic drugs are found in the literature. |
| PubMedID- 25878665 | The rate of metabolic syndrome and diabetes in patients with schizophrenia is higher than the general population. |
| PubMedID- 24682777 | There is no doubt that antipsychotic treatment is strongly associated with the development of metabolic syndrome in schizophrenia (hasnain et al. |
| PubMedID- 21185157 | Association between htr2c polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. |
| PubMedID- 22926590 | Higher prevalence rates of metabolic syndrome (mets) in patients with schizophrenia are getting more and more attention. |
| PubMedID- 25762938 | Metabolic syndrome in schizophrenia patients can be partially explained as a side-effect of antipsychotic medications (448). |
| PubMedID- 21994515 | Genetic polymorphisms in the htr2c and peroxisome proliferator-activated receptors are not associated with metabolic syndrome in patients with schizophrenia taking clozapine. |
| PubMedID- 24955550 | Saffron aqueous extract prevents metabolic syndrome in patients with schizophrenia on olanzapine treatment: a randomized triple blind placebo controlled study. |
| PubMedID- PMC2945179 | The prevalence of metabolic syndrome among people with schizophrenia was 36.6% in men and 54.2% in women (21), far above the levels of 25.1% and 19.7%, respectively, in the overall u.s. population. |
| PubMedID- 24837425 | Metabolic syndrome is associated with both schizophrenia and antipsychotic medication, especially clozapine, with alterations in inflammatory cytokines and adipokines. |
| PubMedID- 22503355 | Prevalence of metabolic syndrome in patients with schizophrenia in india. |
| PubMedID- 22903391 | Lurasidone’s low propensity for weight gain and minimal effect on glucose and lipid parameters may be an important treatment consideration, especially in light of the increased rate of metabolic syndrome among patients with schizophrenia (correll et al. |
| PubMedID- 22796278 | Moreover, strategies to reduce inflammation and obesity may prevent metabolic syndrome in patients with schizophrenia who take atypical antipsychotic medication. |
| PubMedID- 20850274 | Prevalence of metabolic syndrome among patients with schizophrenia in japan. |
| PubMedID- 20643418 | The results support the utility of screening and genetic testing to identify genetic syndromes in adults with schizophrenia in clinical practice. |
| PubMedID- 23528272 | In people with schizophrenia, rates of obesity and the metabolic syndrome are high compared to the general population. |
| PubMedID- 24249923 | To help the psychiatrists to focus more on these cardiovascular risks in patients with schizophrenia, the concept of metabolic syndrome (mets) has received a lot of attention in psychiatric literature. |
| PubMedID- 23153955 | The aetiology of the metabolic syndrome in schizophrenia is multi-factorial and may involve antipsychotic treatment, high levels of stress and unhealthy lifestyle, such as poor diet. |
| PubMedID- 22841467 | [metabolic syndrome in patients with schizophrenia and antipsychotic treatment]. |
| PubMedID- 20425584 | Metabolic syndrome associated with schizophrenia and atypical antipsychotics. |
| PubMedID- 21791046 | This study aimed to investigate the degree that antipsychotic polypharmacy contributed to metabolic syndrome in outpatients with schizophrenia, after adjustment for the effects of lifestyle. |
| PubMedID- 21105277 | The prevalence of the metabolic syndrome is increased in patients with schizophrenia compared with the general population. |
| PubMedID- 22154487 | [metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake]. |
| PubMedID- 20683849 | The objective of this multinational, cross-sectional, pharmacoepidemiological study was to determine the prevalence of diabetes, lipid disorders, obesity, hypertension and the metabolic syndrome in patients with schizophrenia treated with antipsychotic drugs. |
| PubMedID- 21772644 | There are limited data on the prevalence of metabolic syndrome in patients with schizophrenia at the onset of the disorder and, specifically, no data on patients treated in the era when only first-generation antipsychotics were available. |
| PubMedID- 22592510 | A possible stratification of the risk of metabolic syndrome in patients with schizophrenia receiving atypical antipsychotic drugs is as follows: minimal-risk societies are constituted by societies living in eastern asian countries, whereas intermediate-risk societies are constituted by societies living in western asia and south america, and high-risk societies are societies living in australia. |
| PubMedID- 20923919 | A uk systematic review and meta-analysis examined the relative risk of diabetes, dyslipidaemia, hypertension and metabolic syndrome in people with smi including schizophrenia (osborn et al., 2008). |
| PubMedID- 25568478 | Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit. |
| PubMedID- 22044502 | Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a german observational study. |
| PubMedID- 23286356 | schizophrenia patients with metabolic syndrome (mets) (35%) had a 23.9% lower (p<0.001) sbj-score and 22.4% (p<0.001) lower 6mwt-score than those without mets. |
| PubMedID- 23270504 | Prevalence of metabolic syndrome among patients with schizophrenia in palestine. |
| PubMedID- 22970386 | To improve quality of life and decrease metabolic syndrome in patients with schizophrenia, it is essential for caregivers to support patients' drug administration with a minimal effective dose, and aripiprazole is considered to be one of the most effective options available. |
| PubMedID- 23882141 | Conclusion: this study showed that the prevalence of metabolic syndrome in patients with schizophrenia was higher than the overall rate but was slightly lower than in the general population in the usa. |
| PubMedID- 24647221 | The aim of this study was to investigate the characteristics of cognitive function damage in chronic schizophrenia patients with metabolic syndrome (ms); 388 patients were divided into two groups: ms group (180 people with schizophrenia and ms) and non-ms group (208 people with schizophrenia but without ms). |
| PubMedID- 22438935 | In patients suffering from schizophrenia, a high incidence of metabolic syndrome or coronary heart disease (chd) have frequently been reported [1], [2]. |
| PubMedID- 23341251 | Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate. |
| PubMedID- 26093599 | [the stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial]. |
| PubMedID- 25034455 | Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics. |
| PubMedID- 26004686 | We aimed to determine the prevalence of metabolic syndrome among patients with schizophrenia who were antipsychotic drug-naive or drug-free and their siblings for comparison with healthy controls. |
| PubMedID- 25126357 | Objectives: to summarize the current literature on atypical antipsychotic-induced metabolic syndrome in patients with schizophrenia, outline some of the molecular mechanisms behind this syndrome, identify demographic and disease-related risk factors, and describe cost-effective methods for surveillance. |
| PubMedID- 25917886 | The principal objective of this study was to investigate the relationship between sensory gating deficit and metabolic syndrome in patients with schizophrenia, after adjusting for key confounding factors. |
| PubMedID- 22747854 | Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in singapore. |
| PubMedID- 21477998 | Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the clamors study. |
| PubMedID- 22120854 | Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (cures-104). |
| PubMedID- 26090224 | The prevalence of metabolic syndrome among individuals with schizophrenia varied between 19 and 29%, depending on the measurement criteria [66, 67], and 45% had insulin resistance [68]. |
| PubMedID- 21398211 | In this article i review the theoretical and practical aspects of the comorbidity of schizophrenia with metabolic syndrome and diabetes mellitus. |
| PubMedID- 24891713 | Its effectiveness, both for positive and negative symptom schizophrenia with lower chances of metabolic syndrome, will help psychiatrists to treat schizophrenic and related disorders more effectively. |
| PubMedID- 23337566 | Conclusion: the prevalence of metabolic syndrome in schizophrenia patients receiving antipsychotic monotherapy in malaysia was very high. |
| PubMedID- 22541717 | Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. |
Page: 1 2